---
layout: page
title: Research
---

I am interested in developing scalable, structured, and interpretable Bayesian methods, with a focus on Bayesian nonparametrics. These often involve building probabilistic models, with particular interests being: 

(1) incorporating prior information relevant to a specific problem of interest, 

(2) bypassing existing computational bottlenecks, and 

(3) obtaining provable theoretical guarantees. 

As a part of the global [OHDSI](https://ohdsi.org/) community, I am passionate about delivering reliable clinical evidence from massive observational healthcare data-driven studies.

<!--- Earlier, I had 

1. Collaborated with [Dr. Antik Chakraborty](https://antik015.github.io/) in developing [**Nearest Neighbor Dirichlet Mixtures**](https://arxiv.org/abs/2003.07953), a scalable method for density estimation as an alternative to traditional Bayesian density estimators such as the [Dirichlet process mixture model](https://www.gatsby.ucl.ac.uk/~ywteh/research/npbayes/dp.pdf). 
2. Developed [**Synergistic Antagonistic Interaction Detection**](https://arxiv.org/abs/2210.09279), an interpretable and efficient method for detection of synergistic and antagonistic interactions between chemical exposures in epidemiological data, in collaboration with [Dr. Stephanie M. Engel](https://sph.unc.edu/adv_profile/stephanie-m-engel-phd/). --->

# Preprints

1. **Chattopadhyay, S.**, Bu, F., Schuemie, M. J., ..., Suchard, M. A. (2024). Comparative performance of the concurrent comparator design with existing vaccine safety surveillance approaches on real-world observational health data. (preprint available upon request)
2. **Chattopadhyay, S.**, Zhang, A. R., & Dunson, D. B. (2024). Blessing of dimension in Bayesian inference on covariance matrices. arXiv preprint arXiv:2404.03805. [(Link)](https://arxiv.org/abs/2404.03805)

# Publications

1. Morales, D. R., Bu, F., Viernes, B., DuVall, S. L., Matheny, M. E., Simon, K. R., Falconer, T., Richter, L. R., Ostropolets, A., Lau, W. C. Y., Man, K. K. C, **Chattopadhyay, S.**, ..., Suchard, M. A. (2025). Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study. _Diabetes Care_, dc250154.
2. **Chattopadhyay, S.**, Engel, S. M., & Dunson, D. (2025). Inferring synergistic and antagonistic interactions in mixtures of exposures. _The Annals of Applied Statistics_, 19(1), 169-190.
3. Khera, R., Aminorroaya, A., Dhingra, L.S., Thangaraj, P.M., Camargos, A.P., Bu, F., Ding, X., Nishimura, A., Anand, T.V., Arshad, F. and Blacketer, C., Chai, Y., **Chattopadhyay, S.**, ..., Suchard, M. A. (2024). Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study. _Journal of the American College of Cardiology_, 84(10), 904-917. [(Link)](https://www.jacc.org/doi/abs/10.1016/j.jacc.2024.05.069)
4. **Chattopadhyay, S.**, Chakraborty, A., & Dunson, D. B. (2023). Nearest Neighbor Dirichlet Mixtures. _Journal of Machine Learning Research_. [(Link)](https://www.jmlr.org/papers/v24/21-0116.html)
5. Maitre, L., Guimbaud, J. B., Warembourg, C., GÃ¼il-Oumrait, N., Petrone, P. M., Chadeau-Hyam, M., ... & **Exposome Data Challenge Participant Consortium**. (2022). State-of-the-art methods for exposure-health studies: results from the exposome data challenge event. _Environment International_. [(Link)](https://www.sciencedirect.com/science/article/pii/S016041202200349X)

